Targeting the Warburg Effect in Cancer: Where Do We Stand?
I Barba, L Carrillo-Bosch, J Seoane - International Journal of Molecular …, 2024 - mdpi.com
The Warburg effect, characterized by the preferential conversion of glucose to lactate even
in the presence of oxygen and functional mitochondria, is a prominent metabolic hallmark of …
in the presence of oxygen and functional mitochondria, is a prominent metabolic hallmark of …
Mitotic Functions and Characters of KIF11 in Cancers
W Gao, J Lu, Z Yang, E Li, Y Cao, L Xie - Biomolecules, 2024 - mdpi.com
Mitosis mediates the accurate separation of daughter cells, and abnormalities are closely
related to cancer progression. KIF11, a member of the kinesin family, plays a vital role in the …
related to cancer progression. KIF11, a member of the kinesin family, plays a vital role in the …
Eg5 and Diseases: From the Well‐Known Role in Cancer to the Less‐Known Activity in Noncancerous Pathological Conditions
A Ricci, S Carradori, A Cataldi… - Biochemistry Research …, 2024 - Wiley Online Library
Eg5 is a protein encoded by KIF11 gene and is primarily involved in correct mitotic cell
division. It is also involved in nonmitotic processes such as polypeptide synthesis, protein …
division. It is also involved in nonmitotic processes such as polypeptide synthesis, protein …
Hypoxia-inducible PRMT2 addiction in glioblastomas
F Dong, X Sun, J Su, Q Li, Y He, W Li, B Wang… - Cellular …, 2024 - Elsevier
Hypoxia-inducible transcription factors (HIFs) are key transcription factors for cellular
response to low oxygen levels. However, the specific mediators responsible for activating …
response to low oxygen levels. However, the specific mediators responsible for activating …
Silencing BMAL1 promotes M1/M2 polarization through the LDHA/lactate axis to promote GBM sensitivity to bevacizumab
F Wang, W Liao, C Li, L Zhu - International Immunopharmacology, 2024 - Elsevier
Objective Glioblastoma (GBM) has poor clinical prognosis due to limited treatment options.
In addition, the current treatment regimens for GBM may only slightly prolong patient …
In addition, the current treatment regimens for GBM may only slightly prolong patient …
A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignancies
C Zhao, Y Zeng, N Kang, Y Liu - Drug Development Research, 2024 - Wiley Online Library
Drug resistance of malignant tumor leads to disease progression be the bottleneck in clinical
treatment. Antiangiogenic therapy, which aims to “starve” the tumor by inhibiting …
treatment. Antiangiogenic therapy, which aims to “starve” the tumor by inhibiting …
Small molecule drug discovery for glioblastoma treatment based on bioinformatics and cheminformatics approaches
L Feng, S Zhu, J Ma, J Huang, X Hou, Q Qiu… - Frontiers in …, 2024 - frontiersin.org
Background: Glioblastoma (GBM) is a common and highly aggressive brain tumor with a
poor prognosis for patients. It is urgently needed to identify potential small molecule drugs …
poor prognosis for patients. It is urgently needed to identify potential small molecule drugs …